US Patent 7135467 HIV integrase inhibitors
Patent 7135467 was granted and assigned to Bristol-Myers Squibb on November, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Hatice Belgin Gulgeze0
John Matiskella0
Margaret E. Sorenson0
Michael A. Walker0
Narasimhulu B. Naidu0
Yasutsugu Ueda0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+89 characters)
Article
Patent abstract
Compounds useful for treating HIV are disclosed having the general formula
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07135467 HIV integrase inhibitors US Patent 7135467 HIV integrase inhibitors
Infobox
Patent Number
071354670
Patent Number
71354670
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071354670
Date of Patent
November 14, 2006
0Patent Application Number
107556420
Date Filed
January 12, 2004
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07135467 HIV integrase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07135467
Date of patent
November 14, 2006
Patent application number
10755642
Date Filed
January 12, 2004
Patent primary examiner
Find more entities like US Patent 7135467 HIV integrase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
